Search Results - oliver+laeyendecker

2 Results Sort By:
Antibodies associated with HIV control
Value Proposition·      Target associated with viral load reduction identified from a large pool of study participants who had low level viremia·      Potential to reduce disease severity in at-risk populations·      Proactive approach to lower viral load in individuals who could become infected Unmet NeedHuman immunodeficiency virus (HIV) impacts millions...
Published: 3/14/2025   |   Inventor(s): Susan Eshleman, Harry Larman, Kai Kammers, Oliver Laeyendecker, Wendy Grant-McAuley
Keywords(s):  
Category(s): Clinical and Disease Specializations > Infectious Diseases > HIV, Clinical and Disease Specializations > Infectious Diseases > HIV/AIDS, Technology Classifications > Therapeutic Modalities > Antibodies, Technology Classifications > Therapeutic Modalities > Therapeutic Antibodies
HIV Serosignatures for Cross-sectional Incidence Estimation
Unmet NeedAccording to UNAIDS, there were approximately 36.9 million people worldwide living with HIV/AIDS in 2017.  An estimated 1.8 million individuals worldwide became newly infected with HIV in 2017 – about 5,000 new infections per day.Measuring the incidence of HIV in a population is important for improving at-risk populations and intervention...
Published: 3/14/2025   |   Inventor(s): Susan Eshleman, Oliver Laeyendecker, Harry Larman, Kai Kammers
Keywords(s): Clinical Diagnostics, Diagnostic Tool, Disease Indication, HIV/AIDS, Infectious Diseases, Measurement Tool
Category(s): Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > Prognostic Biomarkers
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum